# ARA-290 (ARA 290) and neuropathic pain: a rat study

Source: https://pepvault.app/research/ara-290-swartjes-2014

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [ARA-290](https://pepvault.app/research#ara-290)

Animal study · rats

# ARA-290 eased nerve-injury pain for up to 20 weeks in rats

Checked against the paper November 2026 Animal study [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In rats, a short early course of ARA-290 after nerve injury was followed by reduced pain responses lasting up to 20 weeks.

- **Kind:** Animal study
- **Studied in:** Rats
- **Published:** 2014
- **Journal:** Mol Pain

## What they tested

The team tested whether different doses of ARA-290 reduce pain after a nerve injury in rats, and how it affects microglia and astrocytes, immune-type support cells in the spinal cord.

## How the study was done

An animal study in rats given a spared nerve injury, treated with vehicle (an inactive carrier) or ARA-290 at 3, 10, 30 or 60 μg/kg on days 1, 3, 6, 8 and 10. Spinal cord tissue was examined at 2 or 20 weeks after injury or sham surgery.

<!--promo-->

PepVault for iPhone

## Taking ARA-290? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

In rats, ARA-290 lowered mechanical allodynia (pain from light touch) in a dose-related way for up to 20 weeks compared with vehicle. Cold allodynia was also reduced for up to 20 weeks at all four doses. At 2 weeks, vehicle-treated rats showed increased microglia activity in the L5 spinal segment while rats given 10 or 30 μg/kg did not; at 20 weeks only the 30 μg/kg group stayed free of increased microglia activity. Astrocyte reaction did not differ between groups.

## What it doesn’t show

Every result comes from rats with a surgical nerve injury, and no people were tested. The calmer spinal microglia and the pain relief were seen together, which hints at a link but does not prove one causes the other.

## The paper

Swartjes et al. ARA 290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain coupled with suppression of the spinal microglia response. Mol Pain. 2014.

- [PubMed (PMID 24529189)](https://pubmed.ncbi.nlm.nih.gov/24529189/)
- [The paper (DOI 10.1186/1744-8069-10-13)](https://doi.org/10.1186/1744-8069-10-13)

## The compound

- [ARA-290: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/ara-290)
- [ARA-290 dose guide](https://pepvault.app/lab/dosage/ara-290)

## With this study

### ARA-290

- [ARA-290: the full reference](https://pepvault.app/peptides/ara-290)
- [ARA-290 dose guide](https://pepvault.app/lab/dosage/ara-290)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/ara-290-10mg)

### Studies

- [ARA-290: more corneal nerve fibers at 28 days in sarcoidosis, 4 mg arm](https://pepvault.app/research/ara-290-culver-2017)
- [ARA-290 eased neuropathic symptoms in sarcoidosis nerve fiber loss](https://pepvault.app/research/ara-290-dahan-2013)
- [ARA-290 improved small fiber neuropathy symptoms in sarcoidosis](https://pepvault.app/research/ara-290-heij-2012)
- [All 4 studies](https://pepvault.app/research#ara-290)

### Compared with

- [BPC-157 vs ARA-290](https://pepvault.app/peptides/compare/bpc-157-vs-ara-290)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

## More studies on ARA-290

- [ARA-290: more corneal nerve fibers at 28 days in sarcoidosis, 4 mg arm](https://pepvault.app/research/ara-290-culver-2017) Randomized trial · people · 2017
- [ARA-290 eased neuropathic symptoms in sarcoidosis nerve fiber loss](https://pepvault.app/research/ara-290-dahan-2013) Randomized trial · people · 2013
- [ARA-290 improved small fiber neuropathy symptoms in sarcoidosis](https://pepvault.app/research/ara-290-heij-2012) Randomized trial · people · 2012
- [Every study on ARA-290](https://pepvault.app/research#ara-290)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking ARA-290? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking ARA-290? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### ARA-290

- [ARA-290: the full reference](https://pepvault.app/peptides/ara-290)
- [ARA-290 dose guide](https://pepvault.app/lab/dosage/ara-290)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/ara-290-10mg)

### Studies

- [ARA-290: more corneal nerve fibers at 28 days in sarcoidosis, 4 mg arm](https://pepvault.app/research/ara-290-culver-2017)
- [ARA-290 eased neuropathic symptoms in sarcoidosis nerve fiber loss](https://pepvault.app/research/ara-290-dahan-2013)
- [ARA-290 improved small fiber neuropathy symptoms in sarcoidosis](https://pepvault.app/research/ara-290-heij-2012)
- [All 4 studies](https://pepvault.app/research#ara-290)

### Compared with

- [BPC-157 vs ARA-290](https://pepvault.app/peptides/compare/bpc-157-vs-ara-290)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

<!--promo-->

PepVault for iPhone

## Taking ARA-290? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on ARA-290](https://pepvault.app/research#ara-290)

## The library

- [ARA-290](https://pepvault.app/peptides/ara-290)
- [ARA-290 dose guide](https://pepvault.app/lab/dosage/ara-290)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
